Physician profile
Robert M Jones
NPI 1295788461
$4,366.51
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,534 · 2020: $1,391 · 2021: $441.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,421.29 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $476.49 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $427.85 | 2019-2021 | |
| Janssen Biotech, INC. | $408.94 | 2019-2021 | |
| Lilly USA, LLC | $343.43 | 2019-2021 | |
| Amgen INC. | $199.11 | 2019-2021 | |
| Celgene Corporation | $184.77 | 2019 | |
| Sun Pharmaceutical Industries INC. | $177.52 | 2019-2021 | |
| Leo Pharma INC. | $162.04 | 2019-2021 | |
| Genzyme Corporation | $107.39 | 2019-2020 | |
| Dermira, INC. | $85.29 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $75.77 | 2019-2020 | |
| Sandoz INC. | $66.08 | 2019 | |
| Genentech USA, INC. | $64.98 | 2019 | |
| Galderma Laboratories, L.P. | $30.47 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $29.58 | 2019 | |
| Promius Pharma LLC | $25.25 | 2019 | |
| Merck Sharp & Dohme LLC | $22.74 | 2019 | |
| Biofrontera INC. | $16.37 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.27 | 2019 | |
| Pfizer INC. | $13.61 | 2020 | |
| Ucb, INC. | $11.27 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.